Life Technologies, Advanced Cell Diagnostics Sign Global Distribution Agreement

By: Benzinga
Life Technologies Corporation (NASDAQ: LIFE ) and Advanced Cell Diagnostics, Inc. (ACD), a leader in the field of molecular pathology and developer of cell and tissue-based analysis tools, today announced a global distribution agreement by which Life will distribute ACD's fluorescent RNAscope® portfolio of probes and kits to the
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.